Mounjaro Injection Long-Term Side Effects
Mounjaro was approved for the treatment of Type 2 diabetes relatively recently, in 2022. Because of this, doctors and researchers are still collecting long-term data on people who use the medication for several years. That said, based on existing clinical trials and what is already known about similar GLP-1–based medicines, certain long-term risks and considerations have been identified.
1. Thyroid C-Cell Tumours (Boxed Warning)
The most serious long-term concern is highlighted in the FDA’s boxed warning. In animal studies involving rats, tirzepatide was associated with the development of thyroid C-cell tumours, including Medullary Thyroid Carcinoma (MTC).
- What this means for humans: It is still not known whether Mounjaro causes these tumours in people. However, as a precaution, Mounjaro should not be used if you:
- Have a personal or family history of Medullary Thyroid Carcinoma (MTC)
- Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Your doctor will usually screen for these risk factors before prescribing the medication.
2. Potential for Gastroparesis
Mounjaro works by slowing down how quickly the stomach empties food. Over long periods, there is concern that this effect could contribute to severe or persistent gastroparesis, sometimes described as “stomach paralysis.”
While this remains rare, there have been anecdotal reports and ongoing investigations into whether long-term suppression of gastric emptying could lead to chronic digestive symptoms, even after stopping the medication. Symptoms may include ongoing nausea, bloating, early fullness, or vomiting.
3. Muscle Mass Reduction
Rapid and sustained weight loss, regardless of how it is achieved, can result in the loss of both fat and muscle. With long-term use of appetite-suppressing medications like Mounjaro, inadequate protein intake or lack of strength training may increase the risk of sarcopenia, or age-related muscle loss.
Loss of muscle mass can reduce physical strength, lower metabolic rate, and affect mobility over time. Maintaining sufficient protein intake and including resistance or strength-based exercise is important during long-term treatment.
4. Malnutrition and Nutrient Deficiencies
Long-term appetite suppression may increase the risk of nutritional deficiencies if meals are skipped or food choices lack variety. Eating less overall means that meals need to be more nutrient-dense to meet vitamin and mineral needs.
Without careful planning, deficiencies in nutrients such as protein, iron, vitamin B12, or other essential micronutrients may develop over time. Regular dietary review and, in some cases, supplementation may be needed to support long-term health.
As long-term research continues, regular follow-up with your healthcare provider remains essential. Ongoing monitoring helps ensure that the benefits of Mounjaro continue to outweigh any potential risks over time.